Cargando…

Successful treatment of a critical COVID-19 patient with tocilizumab

Detalles Bibliográficos
Autores principales:	Tsao, Shih-Ming, Wang, Jann-Yuan, Li, Chien-Feng, Hsieh, Ming-Chang, Wang, Yao-Tung, Chan, Kuei-Chuan, Pan, Hui-Hsien, Lee, Yuan-Ti, Huang, Yi-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Formosan Medical Association. Published by Elsevier Taiwan LLC. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584881/ https://www.ncbi.nlm.nih.gov/pubmed/33168277 http://dx.doi.org/10.1016/j.jfma.2020.10.021

Ejemplares similares

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
por: Chuang, Tzu-Yi, et al.
Publicado: (2021)

Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
por: Huang, Thomas Tao-Min, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

A case series report on successful management of patients with COVID-19-associated lymphopenia and potential application of PG2
por: Wang, Wei-Yao, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
por: Teng, Fei, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose
por: Jain, Siddharth, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis
por: Li, Chien-Feng, et al.
Publicado: (2020)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019
por: Mombrun, Martin, et al.
Publicado: (2021)

Deployment of information technology to facilitate patient care in the isolation ward during COVID-19 pandemic
por: Tsai, Ming-Ju, et al.
Publicado: (2020)

Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma
por: Eberst, Lauriane, et al.
Publicado: (2020)

First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19
por: Mastroianni, Fiore
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
por: Horby, Peter, et al.
Publicado: (2021)

Basilar artery occlusion successfully treated with delayed intravascular intervention and mild hypothermia
por: Wang, Dong-Mei, et al.
Publicado: (2019)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab
por: Goto, Kazuya, et al.
Publicado: (2022)

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022)

Highlighting the Concepts of Local Exhaust Ventilation in Negative-Pressure Rooms
por: Kao, Chia-Lung, et al.
Publicado: (2021)

Cover the Patients’ Mouths While Obtaining Nasopharyngeal Specimens
por: Kao, Chia-Lung, et al.
Publicado: (2021)

Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients
por: Zeng, Jia, et al.
Publicado: (2020)

Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
por: Leclercq, Mathilde, et al.
Publicado: (2023)

Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2020)

Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy: A meta-analysis
por: Hung, Hung-Chang, et al.
Publicado: (2019)

Geographic Tongue as an Indicator of Disease Activity to Determine Treatment Goals in Generalised Pustular Psoriasis
por: Wu, Shou-En, et al.
Publicado: (2023)

A mysterious surge of aspergillosis among non-SARS-CoV-2 patients during COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

De-isolation criterion of real-time PCR test in patients with COVID-19: Two or three consecutive negative nasopharyngeal swabs?
por: Syue, Ling-Shan, et al.
Publicado: (2021)

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia
por: Wang, Jing-Zhi, et al.
Publicado: (2021)

Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
por: Ammirati, Enrico, et al.
Publicado: (2020)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Impact of Interleukin-6 Receptor Blockade With Tocilizumab on Cardiac Injury in Patients With COVID-19: A Retrospective Cohort Study
por: Weber, Brittany N, et al.
Publicado: (2021)

“Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital”
por: Barthwal, M. S., et al.
Publicado: (2023)

Successful treatment of granulomatosis with polyangiitis using tocilizumab combined with glucocorticoids: A case report
por: Tang, Peng-Fang, et al.
Publicado: (2023)

A seroprevalence study of COVID-19 at a campus in southern Taiwan
por: Li, Ming-Chi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ldlnh16oku7ifvqtspbjsc12q